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Abstract
Background There is a debate in the health economics litera-
ture concerning the most appropriate way of applying Amartya
Sen’s capability approach in economic evaluation studies.
Some suggest that quality-adjusted life years (QALYs) alone
are adequate while others argue that this approach is too narrow
and that direct measures of capability wellbeing provide a more
extensive application of Sen’s paradigm.
Objective This paper empirically explores whether
QALYs provide a good proxy for individual capabilities.
Methods Data is taken from a multinational cross-sectional
survey of individuals with seven health conditions (asthma,
arthritis, cancer, depression, diabetes, hearing loss, heart dis-
ease) and a healthy population. Each individual completed the
ICECAP-A measure of capability wellbeing for adults and six
health utility instruments that are used to generate QALYs,
including EQ-5D and SF-6D. Primary analysis examines how
well health utility instruments can explain variation in the
ICECAP-A using ordinary least squares regression.
Results The findings show that all seven health conditions
have a negative association on overall capability as measured
by the ICECAP-A index. Inclusion of health utility instru-
ments into separate regressions improves the predictive power
of capability but on average, explains less than half of the
variation in capability wellbeing. Individuals with arthritis
appear to be less inhibited in terms of capability losses when
accounting for health utility, yet those who have depression
record significant reductions in capability relative to the
healthy population even after accounting for the most com-
monly used health utility instruments.
Conclusion The study therefore casts doubt on the ability
of QALYs to act as a reliable proxy measure of individu-
als’ capability.
Key Points for Decision Makers
This study adds empirical evidence to the debate in
health economics as to whether the quality-adjusted life
years (QALY) can provide a comprehensive outcome
of societal welfare benefit as well as a measure of life
years adjusted for health-related quality of life.
We find that the commonly used measures to generate
QALYs, like EQ-5D and SF-6D, perform relatively
poorly in explaining individual capability wellbeing,
measured using the ICECAP-A capability index.
This study therefore casts doubt over whether
QALYs as commonly constructed provide a good
proxy of individuals’ broader capabilities, as has
been previously argued.
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1 Background
Nobel-prize-winning economist, Amartya Sen, provided a
viable alternative to welfare economic analyses through
shifting the evaluative space from a solitary focus on
utilities, in terms of desire fulfilment, happiness or life
satisfaction, to individual capabilities [1–4]. Capabilities
represent the practical opportunities or choices available to
realise valuable states of being, also known as ‘function-
ings’. These include achievements such as good health,
adequate nourishment and adequate shelter [5]. Although
the theoretical application of the capability approach to
health is not new in the economics literature and dates back
over a quarter a century [6, 7], there has been a
notable increase in interest in more recent times in terms of
its normative relevance for health economics [8–12], global
health policy [13] and health care ethics [14, 15]. Simul-
taneously, there have been efforts to measure capability
directly, particularly within health economics for the pur-
pose of assessing benefits from interventions, with a
number of different measurement instruments being
developed in health and social care, public health and
mental health [16].
Early views amongst health economists were that the
capability approach offered additional insights compared
with methods based upon welfare economics [6], which
assumes that social welfare is a function of utility, meaning
individual preferences. The product combination of health-
related utility with life years results in quality-adjusted life
years (QALYs) or disability-adjusted life years (DALYs)
when disutility is used in conjunction with life years [17].
In the case of QALYs, utility has increasingly been mea-
sured using one of a limited number of instruments [18].
These preserve the primary focus upon utility but due to the
relaxation of a number of welfare economic principles,
health economic evaluations using QALYs derived in this
manner have been more commonly described as being
theoretically based on ‘extra welfarism’ [19, 20]. This
deviation from strict welfare economic theory has some-
times been misunderstood as a direct application of Sen’s
capability approach in its entirety, with it being utilised in
part to justify the use of outcomes of health-related mor-
bidity and mortality like QALYs [6] and DALYs [21] in
health economic analysis. For scholars advocating the use
of both the capability approach [22] and welfare economics
[23] in health economic evaluations, this claim is disputed.
Sen’s capability approach is notably underspecified in
how it should be applied to aid public policy making [24],
and this proves to be both a benefit and a disadvantage. It is
beneficial in terms of flexibility, allowing a breadth of
application across disparate fields such as health, education
and technology [25]. However, this under-specification
also causes problems when proposing alternatives in which
a ‘reference case’ analysis is favoured by decision makers,
such as the recommended economic evaluation format
taken by the National Institute for Health and Care
Excellence (NICE) in the UK [26].
Individual capability should be included in health
economic analyses; whether the focus should be only
upon people’s achievements—their ‘functionings’—or
people’s capability to achieve is contested. Sen’s example
of fasting versus starving serves as a key example for
focusing on capability: two people, one of whom is
starving and the other of whom is fasting, have compa-
rable functioning in terms of nourishment, but their
capabilities to be nourished are notably different. The
argument is that focusing on functionings alone would
miss important distinctions such as freedoms and choices
between individuals [27].
In health economics, whether the focus should be on
functioning achievement or the capability to achieve has
been widely debated. Cookson [9] and Bleichrodt and
Quiggin [11] have argued for the orthodox extra-welfarist
approach, relying on the QALY as a best estimate or
surrogate measure of a person’s wider capability set (i.e.
the vector of functionings that an individual can choose).
An alternative argument has been made that the reliance on
QALY outcomes focused on health gain is too narrow a
focus to capture the full benefits of interventions from
health and social care [10], with capabilities measured
directly also appearing to be a fuller implementation of the
approach [28].
The theoretical dispute concerning the relevance of the
capability approach for health economic outcomes is only
important if newly developed capability measures give dif-
ferent empirical results which offer additional information
when compared with measures of health, such as the Euro-
Qol instrument, EQ-5D [29], and other measures used in the
conventional QALY approach; that is, capability is empiri-
cally distinct from functioning and the content of capability
instruments is not subsumed by the content of instruments
used to capture changes in quality of life in QALYs. A
hypothesis previously suggested that new measures of
capability, specifically ICECAP measures [30, 31], are
capturing distinct information from traditional ‘health
functioning’ measures, with an emphasis instead on what has
been described as ‘psychosocial wellbeing’ [32]. This
hypothesis has been backed up in another recent study [33],
although both analyses were focused on a single patient
population and one health utility instrument commonly used
to generate QALYs, the EQ-5D [29]. Therefore, the gener-
alisability of this hypothesis requires further investigation
across different health condition populations and health
utility instruments that can be used to generate QALYs.
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In this paper, we aim to address the following question:
whether measures used to produce QALYs are a good
proxy for the estimation of capability. This will be inves-
tigated empirically, using a cross-sectional dataset across
seven different health condition groups and a ‘healthy’
population, collected from four of the G20 countries.
2 Methods
2.1 Dataset
This study uses data collected as part of the Multi-Instru-
ment Comparison (MIC) dataset, a large study of health,
subjective wellbeing and capability measures collected
across different population groups and countries. The data
survey was conducted by a global panel company, CINT
Pty Ltd, using online panels to recruit relevant individuals.
Participants consisted of a healthy population (defined as
reporting 70 or higher on a 0–100 visual analogue scale
measuring overall health) and seven health condition
groups where individuals reported having a primary con-
dition of one of the following: asthma, arthritis, cancer,
depression, diabetes mellitus, hearing loss and heart dis-
ease, across six countries: Australia, Canada, Germany,
Norway, United Kingdom (UK) and the United States
(US). Quotas were employed to get a representative sample
in terms of age, sex and education in the healthy popula-
tion, while target quotas of 150 individuals per health
condition group per country were employed to reach sim-
ilar numbers of health condition groups within and across
countries [34].
This study uses data from one capability wellbeing
measure and six health utility instruments, as well as
information about the primary health condition (if any) of
the respondents. In this study, the focus is on the seven
health condition groups from the four countries with large
native speakers of English in the MIC dataset (Australia,
Canada, UK, US). The ICECAP-A was not included in the
Norway sample and the newly translated German ICECAP-
A requires validation before comparisons can be made with
the English version. Members of the healthy population
from the four countries are also included.
2.2 Measures
2.2.1 Capability Wellbeing
Developed for assessing health and social-care interven-
tions, the ICEpop CAPability instrument for Adults (ICE-
CAP-A) is a short, self-complete, five-part measure of
capability wellbeing, generated through qualitative inter-
views with members of the UK population sampled to
achieve diversity in terms of socio-economic status, eth-
nicity and rural/urban classification [31]. The five capa-
bilities captured by ICECAP-A are phrased as ‘‘being able
to be/have’’. They attempt to capture broad concepts rela-
ted to people’s capability to live a life that they value and
they comprise stability (‘settled and secure’), attachment
(‘love, friendship and support’), autonomy (‘independent’),
achievement (‘achieve and progress’) and enjoyment (‘en-
joyment and pleasure’). The stability attribute concerns
informants’ desire for continuity in their lives in relation to
friends, work and location. The attachment attribute
emphasises how informants placed emphasis on love,
support and social contact. The autonomy attribute reflects
a desire to be one’s own person and not a liability to others.
The achievement attribute represents how informants
placed value on moving forward in life and attaining their
goals. Finally, the enjoyment attribute captures everyday
enjoyment that people want to be able to have in their lives
[31].
The ICECAP-A represents the only attempt as yet to
develop a generic capability index that could be used
across a broad range of adult patient groups and popula-
tions. Conceptually, therefore, it is comparable to generic
health utility measures such as the EQ-5D and the SF-6D,
which are recommended for use in economic evaluations as
they are not focused on specific conditions and therefore
have the ability to assist with allocative decisions across a
wide range of interventions (within the health sector). One
of the distinguishing characteristics of the ICECAP-A
measure (and the related ICECAP-O for older people [30])
is that it contains no direct mention of physical health.
Although this may be of concern for clinical trials focusing
on physical health, it does permit a comparison of capa-
bility wellbeing across public bodies such as education,
justice, social care and other areas that may influence the
demand for health care services.
A number of studies have now been conducted using the
ICECAP-A. These include studies of construct validity
[35], content validity among members of the public [36],
content validity among research professionals [37], and
test–retest reliability [38]. Evidence is also beginning to
emerge with respect to the responsiveness of the measure
in patient groups [39], as well as the impact of different
health conditions on capability [40]. Values for the relative
importance of capability levels were determined through a
best–worst scaling discrete choice experiment (DCE) with
members from the general UK population [41]. The index
for capability scores is anchored on a ‘no capability–full
capability’ 0–1 scale, in which 1 represents ‘full capabil-
ity’, the highest level of capability on all attributes, and 0
represents ‘no capability’ on all attributes.
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2.2.2 Health Utility Instruments
Six health utility instruments that can be used to generate
QALYs are included in this study. The EuroQol instru-
ment, EQ-5D-5L, consists of five dimensions of health-
related quality of life in terms of a person’s mobility, self-
care, usual activities, pain/discomfort and anxiety/depres-
sion. The original measure consisted of three levels across
the five dimensions (EQ-5D-3L) [29]; the measure has
recently been updated to include five levels with an aim to
improve sensitivity and limit the ceiling effects experi-
enced with the three-level version [42]. The SF-6D is a
shortened preference-based version of the Short Form
36-item, ranging from three to six levels, across six
dimensions: physical functioning, role limitations, social
functioning, pain, mental health and vitality [43]. The
Health Utilities Index Mark 3 (HUI3) is a Canadian health
utility measure consisting of eight dimensions: vision,
hearing, speech, ambulation, dexterity, emotion, cognition
and pain. Each dimension has one item per dimension with
five or six levels per item [44]. The Assessment of Quality
of Life-Eight Dimensions (AQoL-8D) is a newly devel-
oped 35-item health utility instrument from Australia,
consisting of two super dimensions of physical and mental
health or eight dimensions: independent living, pain, sen-
ses, mental health, happiness, coping, relationships and
self-worth. There is a primary focus on psychological
quality of life in the AQoL-8D measure [34]. The 15D
health utility instrument was developed in Finland
and consists of 15 items: mobility, vision, hearing,
breathing, sleeping, eating, speech, elimination, usual
activities, mental function, discomfort and symptoms,
depression, distress, vitality and usual activity [45]. The
Quality of Wellbeing Scale (QWB) consists of a lengthy
list of items that capture three aspects of functioning:
mobility, social activity and physical activity in combina-
tion with questions on symptoms [46].
The methods for eliciting population preferences for
health states from the different health utility instruments
vary, with a reliance on a visual analogue scale (VAS) for
the 15D [45] and QWB [47], standard gamble for the HUI3
[44] and SF-6D [43], a combination of time trade-off
(TTO) and DCE for EQ-5D-5L [48], and a VAS/TTO
combination for AQoL-8D [49]. All six health-related
utility instruments rely on population preferences for elic-
iting utilities, although the AQoL-8D values are generated
from a combination of public and mental health patient
preferences [49]. In cases where more than one value set
exists for different measures, given that there is currently
only an ICECAP-A tariff available for the UK, we use the
UK tariffs for the other instruments where available (i.e.
EQ-5D-5L and SF-6D) to retain comparability.
2.3 Analysis
The main analysis in this paper aims to examine the
relationship between capability wellbeing and health
utility and, more specifically, how much of the variation
in the ICECAP-A index can be explained by the health
utility instruments described above. A number of ordinary
least squares (OLS) regressions were undertaken to test
this relationship, where we assume a linear relationship
between the ICECAP-A index and a number of inde-
pendent variables. All regressions were tested for OLS
assumptions concerning normality, heteroscedasticity,
multicollinearity and linearity. Following similar methods
to studies estimating subjective well-being from health
utility measures [50, 51], two regression model structures
are employed:
ICECAP-A index ¼ ai health condition groupð Þ
þ socio-demographic controls ð1Þ
ICECAP-A index ¼ ai health condition groupð Þ
þ bi health utility measureð Þ
þ socio-demographic controls ð2Þ
The dependent variable in all regressions is the overall
value of the ICECAP-A index. Equation (1) describes the
direct association of the health conditions on capability,
controlling for sex, education, country of residence and
age. Reference variables for health condition, sex,
education, country of residence and age are the healthy
population, being female, highest education being no
more than secondary level, residing in the UK and being
18–24 years old. Coefficients reported in these regressions
therefore represent the average differences in the
capabilities of those with different health conditions
relative to the healthy population and the other
confounding dummy variables. Based on previous
research on the construct validity of the ICECAP-A
with the general population [35], we expect that
regressions excluding the health utility instruments will
show that there is a negative association of health
conditions on capability, a positive association of higher
education on capability and no association of age or sex
on capability. No previous studies are available to suggest
the likely impact of residing in different countries on
capability measured by ICECAP-A.
Each of the health utility instruments is then added sepa-
rately into the initial regression to gauge, primarily, the extent
to which they capture the health condition association with
capability. The results can be interpreted as follows: if an
independent variable from Eq. (1) remains statistically sig-
nificantly different from zero (±) once a health utility
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instrument is added to Eq. (2), the health utility instrument
does not fully capture the health condition association with the
overall capability score; if a variable becomes insignificant
when a health utility instrument is added, the association of
the condition on capability is being captured by the health
utility instrument; if a variable changes sign and significance,
the health condition has a larger association with health utility
compared with overall capability.
Additional statistical analysis on mean health and
capability scores, distribution of capability scores, and
correlation analysis between health and capability scores
were also conducted. All analysis was conducted using
STATA.
3 Results
In total, 5240 individuals (4295 from the health condition
groups and 965 from the healthy population) are included
in this study. Individuals excluded for this analysis include
people who reported other conditions (n = 336). Further
information on the inclusion criteria applied to the data
prior to this analysis being undertaken can be found else-
where [51]. Table 1 highlights some of the key socio-de-
mographic information for the individuals included in this
study, including sex, highest education attainment, country
of residence and age group. Table 2 reports the mean
scores across the health and capability measures for the
eight population groups. Figures 1 and 2 show the distri-
bution of capability scores for the healthy population and
health condition population groups. Table 2 also shows the
results of the correlation between ICECAP-A and the six
health scores. The ICECAP-A and AQoL-8D correlation of
0.80 was considerably higher than the next best correla-
tions with the HUI3 and 15D of 0.67.
Table 3 reports the regression analyses showing the
extent to which ICECAP-A values are explained by health
condition groups and socio-demographic controls alone
(regression 1) and with the addition of each of the six
health utility instruments individually (regressions 2–7).
No OLS assumptions tested were violated. Looking at the
prediction of ICECAP-A without health utility instruments
included, the association with capability levels for each of
the seven conditions can be seen, ranging on average from
a 5% reduction in capability for those suffering hearing
loss to almost a 25% reduction in capability for individuals
reporting a primary condition of depression. All seven
conditions have a significant negative association with
capability compared with the healthy population sample.
With respect to other prior expectations, the hypothesised
associations of higher education having a positive associ-
ation and sex having an insignificant association hold.
Being aged between 35 and 54 years has a significant T
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negative association with capability, all else being equal.
Being from Australia, Canada or the US compared with the
UK and being over 65 years of age all have a positive
association with capability. Based on the variables included
in column 2, just over 17% of the variation in the ICECAP-
A capability score is explained by the health condition and
socio-demographic controls alone.
In regressions 2–7 in Table 3, the six health utility
instruments are added to the regression separately. For the
arthritis population, all six health utility regressions report
a positive significant coefficient, suggesting the condition
has a greater association with the six health utility mea-
sures than capability as captured by ICECAP-A. The same
trend is observed for hearing loss on four of the regressions
including health utility measures (not for regressions
including EQ-5D or SF-6D). For people with depression,
five of the six measures produced negative significant
coefficients, underestimating the impact of depression on
capability captured by the ICECAP-A. The addition of
AQoL-8D to the regression (Table 3, regression 4) turns
six health condition variables (except depression) to posi-
tive significant variables, suggesting a larger association
with the AQoL-8D than capability. A similar trend is
recorded on the 15D for the same six health condition
groups.
The addition of EQ-5D and SF-6D to the regression
adds less explanatory power to the ICECAP-A scores
compared with the AQoL-8D, HUI3 and 15D instruments,
Table 2 Capability and health scores (standard deviation) for population groups
ICECAP-A EQ-5D SF-6D AQoL-8D HUI3 15D QWB
Healthy 0.893 (0.13) 0.941 (0.08) 0.802 (0.11) 0.828 (0.15) 0.897 (0.13) 0.950 (0.06) 0.764 (0.14)
Asthma 0.810 (0.17) 0.830 (0.18) 0.700 (0.13) 0.672 (0.21) 0.739 (0.25) 0.839 (0.12) 0.627 (0.14)
Arthritis 0.810 (0.17) 0.731 (0.22) 0.664 (0.13) 0.624 (0.22) 0.599 (0.27) 0.808 (0.12) 0.578 (0.13)
Cancer 0.810 (0.18) 0.787 (0.21) 0.685 (0.13) 0.655 (0.22) 0.676 (0.27) 0.816 (0.13) 0.598 (0.14)
Depression 0.637 (0.22) 0.702 (0.22) 0.603 (0.11) 0.452 (0.19) 0.524 (0.31) 0.757 (0.14) 0.538 (0.13)
Diabetes 0.797 (0.19) 0.776 (0.22) 0.680 (0.14) 0.636 (0.23) 0.648 (0.29) 0.818 (0.13) 0.610 (0.15)
Hearing loss 0.855 (0.16) 0.872 (0.14) 0.749 (0.12) 0.719 (0.20) 0.687 (0.23) 0.875 (0.10) 0.639 (0.12)
Heart disease 0.817 (0.18) 0.786 (0.21) 0.690 (0.13) 0.667 (0.23) 0.678 (0.27) 0.819 (0.14) 0.607 (0.15)
Maximum 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Minimum 0.000 -0.276 0.301 0.105 -0.343 0.253 0.151
Correlation with ICECAP-A 0.613 0.631 0.802 0.669 0.667 0.526
ICECAP-A scores on 0–1 (no capability–full capability) scale. Health scores on 0–1 (dead–full health) scale for use in QALYs
15D 15-dimension health utility instrument, AQoL-8D Assessment of Quality of Life-8 Dimensions, EQ-5D EuroQol-5 Dimensions, HUI3
Health Utilities Index Mark 3, ICECAP-A ICEpop CAPability instrument for Adults, QWB Quality of Wellbeing scale, SF-6D Short Form-6
Dimensions
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Fig. 1 Histogram of ICECAP-A distribution in the healthy popula-
tion (n = 965). ICECAP-A ICEpop CAPability instrument for Adults
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Fig. 2 Histogram of ICECAP-A distribution in the health condition
population (n = 4295). ICECAP-A ICEpop CAPability instrument for
Adults
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respectively. The AQoL-8D regression explains variation
in ICECAP-A values best, with an adjusted R2 of 0.655,
compared with an average adjusted R2 of 0.48 across the
six regressions including the health utility instruments.
4 Discussion
In this study, the debate surrounding whether the QALY
provides a good proxy for measuring individual capability is
empirically tested, using six health-utility instruments and a
measure of perceived capability wellbeing across four coun-
tries, seven health conditions and a healthy population sample.
The main findings of this study show that all health conditions
studied here have negative associations with capability well-
being compared with the healthy population, ranging from a
5% decrement for those with hearing loss to a 25% reduction
for those with depression. On average, the six regressions
including the most common health utility instruments applied
in economic evaluation do not explain the majority of varia-
tion associated with capability well-being as measured by the
ICECAP-A. The EQ-5D and SF-6D, the most frequently used
health utility instruments [52], perform poorly in explaining
variation in capability wellbeing relative to the regressions
including the newly developed AQoL-8D and to a consider-
ably lesser extent, the HUI3 and 15D.
This study examined health utility and capability wellbeing
across a wide variety of health conditions and four nations
with differing healthcare systems, so the results benefit from
this level of comprehensiveness. The large number of health
utility instruments is also an important strength, allowing
conclusions to be drawn for more than one interpretation of
health; it was not possible to achieve similar
Table 3 Regressions
explaining ICECAP-A overall
score (n = 5240)
Variable 1 2 3 4 5 6 7
Health utility
EQ-5D 0.528*
SF-6D 0.794*
AQOL-8D 0.655*
HUI3 0.437*
15D 0.929*
QWB 0.578*
Arthritis -0.087* 0.017* 0.024* 0.051* 0.036* 0.037* 0.018*
Asthma -0.080* -0.020* -0.002 0.018* -0.008 0.024* -0.003
Cancer -0.092* -0.017* 0.005 0.032* -0.001 0.027* 0.004
Depression -0.247* -0.122* -0.095* -0.010 -0.085* -0.071* -0.120*
Diabetes -0.098* -0.017* 0.002 0.033* 0.003 0.018* -0.009
Hearing loss -0.050* -0.015* -0.002 0.035* 0.040* 0.019* 0.026*
Heart disease -0.087* -0.009 0.009 0.032* 0.004 0.032* 0.008
Male 0.000 -0.004 -0.012* -0.015* -0.001 -0.009* -0.016*
University 0.032* 0.012* 0.015* -0.008* -0.003 0.003 0.021*
Dip/cert/trade 0.017* 0.008 0.012* -0.003 0.005 0.005 0.018*
Australia 0.033* 0.012* 0.023* 0.008 0.016* 0.014* 0.026*
USA 0.037* 0.024* 0.029* 0.011* 0.024* 0.026* 0.032*
Canada 0.040* 0.021* 0.022* 0.007 0.019* 0.022* 0.030*
Age 25–34 year -0.008 -0.001 -0.011 -0.002 -0.002 0.004 -0.013
Age 35–44 year -0.032* -0.007 -0.029* -0.013 -0.007 -0.002 -0.028*
Age 45–54 year -0.040* -0.001 -0.035* -0.015* -0.001 0.003 -0.032*
Age 55–64 year -0.011 0.023* -0.018* -0.013 0.021* 0.026* -0.009
Age 65? year 0.044* 0.057* 0.017 -0.005 0.059* 0.060* 0.030*
Constant 0.860* 0.367* 0.249* 0.362* 0.475* -0.019 0.435*
Adjusted R2 0.173 0.442 0.443 0.655 0.510 0.498 0.351
15D 15-Dimension health utility instrument, AQoL-8D Assessment of Quality of Life-8 Dimensions, EQ-
5D EuroQol-5 Dimensions, HUI3 Health Utilities Index Mark 3, ICECAP-A ICEpop CAPability instrument
for Adults, QWB Quality of Wellbeing scale, SF-6D Short Form-6 Dimensions
* Statistically significant where p B 0.05
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comprehensiveness in relation to capability instruments as
there is only one such instrument available for the adult
population.
There are a number of limitations associated with this
dataset, namely the cross-sectional nature of data currently
available and that population groups are split by broad
health condition categories. Therefore, we are unable to
assess important issues related to health status and capa-
bility wellbeing captured on the ICECAP-A with regards to
longitudinal changes of capability over time and whether
improvements in health conditions similarly or differently
effect health utility or capability.
Values for estimating overall scores for the six health
utility instruments and one capability wellbeing instru-
ment were derived from those currently available. How-
ever, the conceptual differences embedded in the
descriptive systems of measures are likely to be of greater
importance than differences in valuation across countries.
Separate analyses of the six health utility instruments
confirms that differences are primarily a result of the
descriptive systems and not the weights applied [53]. It
should be noted that an implicit assumption in the work is
that ICECAP-A provides a strong measure of capability:
it is clearly difficult to test this assumption given that
other generic measures were not available here. Whether
or not capabilities can be self-reported remains a lively
debate in the capability community, as the capability
approach was developed in part to reduce subjective
adaptation in utility measurement [20].
This study has questioned whether measures of health
utility are able to explain capability wellbeing adequately
and whether QALYs created from existing health utility
instruments provide a good proxy measure of capability.
Although this study generates some evidence that health
utility measures are able to explain the health condition
component of capability wellbeing, particularly for physi-
cal health conditions, the regressions including a measure
of health utility failed to explain, on average, half of the
variation in capability wellbeing scores across the broad
sample surveyed here (i.e. mean average adjusted R2 of
0.48 across six regressions ranging from 0.35 to 0.66; see
Table 3).
The impact on capability for individuals with a primary
health condition of depression is underestimated by the
majority of commonly used health utility instruments. The
only measure that captures the capability reduction from
depression is the newly developed AQoL-8D, which has
primarily aimed to redress the perceived imbalance in
existing measures against psychosocial health [34]. The
performance of the more commonly used health utility
instruments in this analysis adds support to a belief that
mental health is unfairly treated using the QALY [54, 55],
and that has led to some researchers developing a
capability measure for mental health patients [56]. The
findings here will similarly support the consensus of other
researchers who have made similar criticisms of the use of
the QALY in non-healthcare settings such as social care
[57], public health [58], end-of-life care [59] and other
complex interventions [60].
This study focused on one main difference between
those advocating a more extensive use of the capability
approach and those committed to the extra-welfarism
approach currently practiced in health economics. Dif-
ferences exist, not only in measurement, but also in
decision rules and valuation where the extra-welfarism
commonly applied remains inherently welfarist in practice
[23, 61]. Progress has been made in developing a capa-
bility approach alternative to standard practice in terms of
measures of capability [16, 62], decision rules by moving
towards a sufficient capability objective [63, 64], and
valuation with best–worst scaling DCE offering a mech-
anism for estimating the relative importance of different
capability states [30]. Further research is still required,
particularly on how a unit of capability gain, however
defined, is monetarily valued before a fully workable
alternative to the conventional QALY approach can be
provided to decision makers. Further research is also
required to understand how measures of perceived capa-
bility like ICECAP-A are susceptible to adaptation over
time.
5 Conclusion
This study has contributed to the growing literature which
seeks to demonstrate the role and value of capabilities in
the analysis of health and related sectors where presently
QALYs are the only economic outcome deemed to be
relevant. Specifically it tested, empirically, whether or not
health utilities used to create QALYs could satisfactorily
measure capabilities across seven common health condi-
tions. The health utility instruments included in this study
were found to have significant but variable explanatory
power depending on the measure used. Nevertheless, none
of the instruments fully predicted or explained levels of
capability wellbeing across a number of health conditions.
Some of the lowest explanatory powers of capability in
regression analysis undertaken here were those that inclu-
ded the most commonly used health utility instruments, the
EQ-5D and SF-6D. This observation provides support for
the addition of information concerning capabilities in
evaluation studies when these health utility instruments are
used.
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